Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands

Hedwig Blommestein, Saskia de Groot, MJ Aarts, P (Pepijn) Vemer, R de Vries, AFM Abeelen, EFM Posthuma, Carin Uyl - de Groot

Research output: Contribution to journalArticleAcademicpeer-review

6 Citations (Scopus)
2 Downloads (Pure)
Original languageEnglish
Pages (from-to)37-45
Number of pages9
JournalLeukemia Research
Volume50
DOIs
Publication statusPublished - 2016

Cite this